Victor Bartsevich
18Patents
8h-index
8Co-inventors
57Inventor score
Filing activity: Sep 8, 2016 → Sep 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9889160B2 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 50 | Active |
| US9889161B2 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 19 | Active |
| US9993502B1 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 13 | Active |
| US10093900B2 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 12 | Active |
| US9969975B1 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 10 | Active |
| US9950011B1 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 9 | Active |
| US9950010B1 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 9 | Active |
| US9993501B2 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 8 | Active |
| US10093899B1 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 5 | Active |
| US10799535B2 | Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 4 | Active |
| US11142750B2 | Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome | Chemistry; Metallurgy | 3 | Active |
| US10603363B2 | Treatment of retinitis pigmentosa using engineered meganucleases | Chemistry; Metallurgy | 1 | Active |
| US11788077B2 | Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome | Chemistry; Metallurgy | 0 | Active |
| US11266693B2 | Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 0 | Active |
| US11268065B2 | Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene | Chemistry; Metallurgy | 0 | Active |
| US11680254B2 | Engineered meganucleases specific for recognition sequences in the PCSK9 gene | Chemistry; Metallurgy | 0 | Active |
| US11278632B2 | Engineered nucleases useful for treatment of hemophilia A | Chemistry; Metallurgy | 0 | Active |
| US10758595B2 | Treatment of retinitis pigmentosa using engineered meganucleases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.